Drapalin 1/17 Maluti CBD is a distinctly indica-dominant hybrid of the cultivars Otto Kush and ACDC with minimal psychoactive properties and a high β-Myrcene content.

The purple hues on the leaves and buds, as well as the grape aroma, give this unique variety the nickname “Grape Cluster.” Its trichomes produce about 15 – 18 % of CBD.

Effect profile

  • Anticonvulsant
  • Muscle relaxant
  • Anti-inflammatory

Recommendation

  • Epilepsy
  • Morbus Parkinson
  • Anxiety

Terpenes encompass a diverse group of volatile and aromatic organic compounds that pervade the intricate botanical structure of the plant’s flowers and leaves. These compounds exhibit structural complexity, characterized by the presence of isoprene units and a plethora of functional groups.
Terpenes play a vital role in the overall chemical composition of cannabis, contributing to its distinct scent, flavour, and potential therapeutic effects. Through their synergistic interactions with other constituents, terpenes have been implicated in modulating the physiological and psychoactive properties of cannabinoids, thereby influencing the intricate pharmacological profile of cannabis-based products.

Cultivar

THC/CBD (m/m)

Treatment

Genetics

Shelf life

Maluti CBD (Hybrid, Indica-dominant)

THC ≤1% CBD 15.3-18.7%

Not irradiated

Otto Kush x ACDC

12 months

Cultivar: Maluti CBD (Hybrid, Indica-dominant)

THC- / CBD-Content (m/m):  THC ≤1% CBD 15.3-18.7%

Treatment: Not irradiated

Genetics: Otto Kush x ACDC

Shelf life: 12 months

Medication
Intake

Medicinal cannabis flowers can be taken both through inhalation (e.g. by means of a vaporizer) and orally (e.g. as a tea preparation). The appropriate route of administration should be determined individually by the prescribing physician together with the patient and must be written down on the prescription.

Areas of
application

Since the prescription of medical cannabis flowers to patients is a formulation prescription, the decision on the therapeutic area of application rests with the prescribing physician. Based on the symptoms, medical cannabis is currently most frequently used in Germany for the following diseases:

Pain

Anorexia / Cachexia

Depression

Lack of appetite

Insomnia

Spacticity

Inflammatory bowel diseases

Epilepsy

ADHD

Multiple Sclerosis

Tic disorders / Tourette Syndrom

Nausea / Vomiting

MG Health is about quality and safety

MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level. The local population’s quality of life has also improved remarkably since the company’s inception five years ago.

MG Health is about quality and safety

MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level. The local population’s quality of life has also improved remarkably since the company’s inception five years ago.

Andre Bothma

CEO of MG Health

"When we started this company, we didn’t just want to make a profit, we wanted to change lives, and what better way to do that than through education and jobs?"

THESE PRODUCTS ARE DISTRIBUTED IN GERMANY BY DRAPALIN

Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin

THESE PRODUCTS ARE DISTRIBUTED IN GERMANY BY DRAPALIN

Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin

Lana Korneva

CEO of DRAPALIN

“We are proud to be the first pharmaceutical wholesaler to supply medical cannabis flowers from Africa to pharmacies throughout Germany since August 2021. In doing so, we have made history together with our Lesotho partner MG Health.”